Approval · Notice of Compliance 16763 · 2015
HALOPERIDOL INJECTION, USP: Notice of Compliance 16763
Issued April 2, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16763
- Date
- April 2, 2015
- Company
- Fresenius Kabi Canada LtdToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antipsychotic agent
- Canadian reference product
- HALOPERIDOL INJECTION (Omega Laboratories Limited)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| HALOPERIDOL INJECTION, USP | 02406411 | Marketed |
Medicinal ingredients
- HALOPERIDOL 5 MG per ML